Volume : 12, Issue : 03, March – 2025
Title:
DEVELOPMENT AND VALIDATION OF HPLC AND SPECTROSCOPIC METHOD OF ESTIMATION OF ANTIHYPERTENSIVE DRUG
Authors :
Vaishnavi Narayan Thakare*, Dr. Anil V. Chandewar
Abstract :
The aim of this research was to develop and validate a stability-indicating Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method for the simultaneous estimation of Lisinopril and Atenolol in pharmaceutical topical dosage forms. The method was designed to be robust, precise, and capable of distinguishing the active pharmaceutical ingredients (APIs) from their degradation products under various stress conditions. Chromatographic separation was achieved using a C18 column (250 mm × 4.6 mm, 5 μm particle size) with a mobile phase consisting of Acetonitrile: Phosphate Buffer (pH 3.00) (60:40). The flow rate was maintained at 1.0 mL/min, and detection was carried out at 231 nm using a UV detector. The retention time of drug was found to be 5.241 and 7.724 for LSP and ANL respectively. The method was validated according to ICH guidelines for linearity, accuracy, precision, specificity, limit of detection (LOD), limit of quantification (LOQ), and robustness. Linearity was observed in the concentration range of 25-150 μg/mL for Lisinopril and 10-60 μg/mL for Atenolol, with correlation coefficients (r²) of 0.998 and 0.999 respectively. The method demonstrated good accuracy, with recovery rates between 98.0% and 102.0% for both drugs. Precision, both intra-day and inter-day, showed relative standard deviation (RSD) values of less than 2%. The developed RP-HPLC method is reliable, efficient, and suitable for the simultaneous estimation of Lisinopril and Atenolol in pharmaceutical oral dosage forms. It can be successfully applied for routine quality control and stability testing of these agents.
Keywords: Lisinopril, Atenolol UV Spectrophotometry, RP-HPLC, Simultaneous Estimation, Method Validation.
Cite This Article:
Please cite this article in press Vaishnavi Narayan Thakare ., Development And Validation Of HPLC And Spectroscopic Method Of Estimation Of Antihypertensive Drug., Indo Am. J. P. Sci, 2025; 12(05).
Number of Downloads : 10
References:
1. Satinder, A., Stephen, S., Hand Book of Modern Pharmaceutical Analysis., Published by Academic Press, London., (2001),(3), 1-2.
2. Yang H, Feng Y and Luan Y., Simultaneous Determination of Simvastatin and Ezetimibe in Tablets by HPLC.,J Chromatogr B., 2003, 785, 369.
3. Srivastava, VK., and Srivastava, KK., Introduction to Chromatography Theory and Practice,14th Edition., S.Chand and Company limited, New Delhi., (1991), 66-67.
4. Sethi PD., Quantitative Analysis of Pharmaceutical Formulations, 1st ed., CBS Publishers and Distributors, New Delhi. (2001), 3-5.
5. Snyder, LR., Joseph Kirkland, J., Joseph Glajch, L., Practical HPLC Method Development., 2nd ed., John Wiley and Sons, INC, Canada., (1997), 2-11.
6. Melani L, Mills R and Hassman D., Efficacy and safety of ezetimibe co- administered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, Double-blind trial., Eur Heart J., 2003, 24, 717-728.
7. Curlucci G, Mazzeo P, Biordi L and Bologna M., Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by high performance liquid chromatography with UV detection, J. Pharm. Biomed. Anal., 1992, 10 (9), 693-697.
8. International Conference on Harmonization, Draft Guideline on Validation of Analytical Procedures: Definitions and Terminology, Federal Register, 60 (1995) 11260.,1996 (1-8).
9. Center for Drug Evaluation and Research, Food and Drug Administration, Reviewer Guidance, Validation of Chromatographic Methods. 1994.
10. Guideline for Submitting Samples and Analytical Data for Methods Validation. Food and Drug Administration, 1987.
11. Sahu, P., & Jain, S. (2008). Development of a UV-Spectrophotometric Method for Estimation of Losartan Potassium in Bulk and Tablet Dosage Forms. Asian Journal of Pharmaceutical and Clinical Research, 1(1), 45-49.
12. Dhawale, P. G., & Bhatt, K. K. (2010). Simultaneous Estimation of Amlodipine and Valsartan by RP-HPLC Method. International Journal of Pharmaceutical Sciences and Research, 1(10), 52-56.
13. Patel, H. R., Patel, M. M., & Patel, N. M. (2012). Development and Validation of RPHPLC Method for Simultaneous Estimation of Amlodipine Besylate and Hydrochlorothiazide in Tablet Dosage Form. International Journal of Pharmaceutical Sciences and Research, 3(5), 1409-1416.
14. Siddiqui, M. R., & Alothman, Z. A. (2014). Validated HPLC Method for the Determination of Atenolol and Hydrochlorothiazide in Human Plasma. International Journal of Analytical Chemistry, 2014,
15. Mubeen, G., & Noor, S. (2015). Development of a UV-Spectrophotometric Method for Simultaneous Estimation of Amlodipine and Losartan Potassium. Asian Journal of Chemistry, 27(7), 2671-2675.
16. Pandya, N., Chavda, J., & Raval, A. (2016). HPLC Method Development and Validation for the Simultaneous Estimation of Valsartan and Hydrochlorothiazide in Tablets. Journal of Pharmaceutical Research, 15(2), 112-116.
17. 24.Jain, D., & Basniwal, P. K. (2017). Spectrophotometric and HPLC Methods for the Simultaneous Estimation of Lisinopril and Hydrochlorothiazide. Journal of Applied Pharmaceutical Science, 7(3), 97-103.
18. Goswami, N., & Kumar, V. (2018). HPLC and UV Spectrophotometric Methods for the Estimation of Anti-Hypertensive Drug Combinations: A Review. Journal of Drug Delivery and Therapeutics, 8(4), 414-426.
19. Permender. R, Sushila. R, Kumar. V and Shyama. T. Simultaneous estimation of Amlodipine Besylate and Lisinopril dehydrate as A.P.I. and in tablet dosage forms by 186 modified form of simultaneous equation method using derivative UVSpectrophotometry. International Journal of Pharm Tech Research, 2(1), 556-562 (2010).
20. Prasad. C.V.N, Saha. R.N and Parimoo. P. Simultaneous determination of Amlodipine-Enalapril maleate and Amlodipine-Lisinopril in combined tablet preparations by derivative spectrophotometry. Pharmacy and Pharmacology Communications, 5(6), 383-388 (1999).
21. Olcay. S and Lale. E. An HPLC method for the determination of Lisinopril in human plasma and urine with fluorescence detection. Journal of Chromatography B, 809(1), 159-165 (2004).
22. El-Emam. A, Hansen. S.H, Moustafa. M.A, El-Ashry. S.M and El-Sherbiny. D.T. Determination of Lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2- oxa-1,3-diazole (NBD-CL) followed by spectrophotometry or HPLC with fluorimetric detection. Journal of Pharmaceutical and Biomedical Analysis, 34(1), 35-44 (2004).
23. Medenica. M, Jancic. B, Knezevic. N, Malenovic. A and Milac. J. Validation of an analytical procedure for simultaneous determination of Hydrochlorothiazide, Lisinopril, and their impurities. Acta Chromatographica, 18, 143-156 (2007).
24. Naveed. S, Syeed Arayne. M and Sultana. N. Validated method for the determination of Lisinopril, Pravastatin, Atorvastatin and Rosuvastatin in API, Formulations and human serum by RP-HPLC. Chinese Journal of Chemistry, 29(6), 1216-1220 (2011).
25. Sathe SR, Bari SB, Simultaneous Analysis of Losartan Potassium, Atenolol, and Hydrochlorothiazide in Bulk and in Tablets by HPTL Chromatography with UV Absorption Densitometry. Acta chromatographica. 2007; 19: 270- 278.
26. Satheesh KS, Quantitative Application to a Polypill by the Development of Stability Indicating LC Method for the Simultaneous Estimation of Aspirin, Atorvastatin, Atenolol and Losartan Potassium. American J. of Analytical Chemistry, 2010; 2: 59-69
27. Oskar G, LC–MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma. J. of Chromatography B, 2010; 878: 2685–2692.
28. Kavitha J, Muralidharan S, Development and Validation of New Method for Atenolol, Hydrochlorothiazide and Losartan potassium by RP-HPLC: Its Application to Routine Quality Control Analysis. International Journal of ChemTech Research. April-June 2010, 2 (2), 880-884
29. https://en.wikipedia.org/wiki/Lisinopril
30. https://en.wikipedia.org/wiki/Atenolol
31. G S Wander, S T Chhabra, K Kaur, “Atenolol Drug Profile”, Supplement of JAPI, 2009, 57; p1-16.
32. https://pubchem.ncbi.nlm.nih.gov/compound/Lisinopril
33. Perveen N, Khan NH. Quantitative determination by UV spectroscopy, structural characterization evaluation by Fourier Transform Infrared Spectroscopy (FTIR) and disintegration analysis of Lisinopril tablets available in the Malaysian outlets. Pharm Pharmacol Int J. 2023;11(3):99-108.
34. Rafael N. Pereira, Bruno R. Valente, Ariane P. Cruz, Talize Foppa, Fabio S. Murakami & Marcos A. S. Silva. Thermoanalytical Study of Atenolol and Commercial Tablets. Lat. Am. J. Pharm. 2007; 26 (3): 382-6.
35. D Noel Preetham, K Sujana, P D S Sankar. Development and Validation of UV Spectrophotometric Method for the Estimation of Lisinopril in Bulk and Pharmaceutical Formulation. Int. J. Pharm. Sci. Rev. Res., 25(1), 2014; 257-259.
36. Shoaeb Syed, Mubashir Mohammed. Validation of UV Spectrophotometric Method for Determination of Atenolol. International Journal of Pharmaceutical Research .2014; 6 (1): 25-27.
37. N. Mallikarjuna Rao and D. Gowrisankar. Stability-indicating HPLC Method for Simultaneous Determination of Atenolol, Aspirin, Lisinopril and Simvastatin in Bulk and Tablets. Indian J Pharm Sci 2016;78 (2):217-223.
38. Vikas Chander, Manindra Mohan, Richa Seth, Prashant Singh, Rakesh Singh , Sanjay Gupta. Development and Validation of RP-HPLC Method for the Estimation of Lisinopril in Tablet Dosage Form. Analytical Chemistry Letters. 2012; 2 (5): 309 – 313.